Medical Weight Loss for Plainfield, New Jersey Residents

Plainfield, New Jersey residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.

Physician-supervised GLP-1 programs from $166/month, serving Plainfield through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.

Skip the commute, keep the care: from downtown Plainfield and the greater Union County area and anywhere else in Plainfield, you meet your physician on a video call from home or work. We confirm telehealth eligibility during the consultation. Doctor review just $119 (medication separate).

Why Plainfield Residents Choose New Hope Weight Loss

Continuity is the quiet advantage Plainfield patients notice most. Because Dr. Anjmun Sharma oversees your case throughout, the person adjusting your dose in month three is the same physician who reviewed you in week one. Nothing gets lost in a handoff. That consistency, delivered by telehealth from our Costa Mesa clinic, is what turns a prescription into actual ongoing care for people all over New Jersey.

Plainfield is part of the area New Hope Weight Loss serves by telehealth. The same compounded semaglutide and tirzepatide protocols, the same flat pricing, and the same bilingual support reach Plainfield patients at home.

If you are searching for a weight-loss physician in Plainfield, the honest answer is that ours is in Costa Mesa, and thanks to telehealth that puts New Jersey patients exactly where local ones are. We care for patients throughout downtown Plainfield and the greater Union County area. Follow-up check-ins are handled remotely, so adjusting your dose is simple whether you live near downtown Plainfield or out toward downtown Plainfield and the greater Union County area.

Wherever you are in Plainfield or the wider New Jersey area, the program reaches you the same way, with HSA, FSA, Klarna, and Affirm all accepted. We accept HSA and FSA cards for the $119 physician review, which lets many Plainfield patients use pre-tax dollars toward their care. New Jersey is one of the most densely populated states in the country, and New Hope Weight Loss serves patients across it by telehealth from our Costa Mesa, California clinic.

GLP-1 Weight Loss Programs Available

Semaglutide (90-Day Metabolic Reset)

From $166/mo, or $499 for 90 days, our reset program is the route most people in Plainfield choose. Semaglutide is the same active ingredient found in Wegovy and Ozempic, and branded-drug studies reported 15 to 17 percent average body-weight loss. Dr. Sharma reviews your dose monthly. Keep in mind that compounded semaglutide is not FDA-approved, is not brand-identical, and that results vary.

Tirzepatide (Dual-Action Program)

From $233/mo, tirzepatide adds a second mechanism, GIP, on top of GLP-1. In clinical trials of the branded drug, dose-qualified patients reached up to 22.5 percent loss, which is not the typical result. Tirzepatide shares its active ingredient with Mounjaro and Zepbound.

Physician review is $119. Medication billed separately. HSA, FSA, Klarna, and Affirm accepted.

How Telehealth Works for Plainfield

Getting started in Plainfield is simple, and you never have to leave home. Begin with a short intake quiz about your health history, weight goals, and any medications you take. Dr. Anjmun Sharma reviews your answers and meets you by secure video, usually within 48 hours, to talk through whether compounded semaglutide or tirzepatide is a reasonable fit. If she prescribes, a state-licensed 503(a) pharmacy ships your medication straight to your Plainfield address in cold-pack packaging that keeps it stable in transit. From there, your follow-up visits happen by video too, so dose checks and questions stay easy no matter where in you live.

Frequently Asked Questions, Plainfield

Can I start with New Hope Weight Loss if I am located in Plainfield?

Yes, you can start from Plainfield right away. Our physical clinic is in Costa Mesa, California, and we deliver care to Plainfield, New Jersey by telehealth. A video consultation with Dr. Anjmun Sharma reviews your medical history and confirms your fit for compounded semaglutide or tirzepatide.

Do appointments require me to leave Plainfield?

They do not. Every appointment is handled by telehealth, so Plainfield patients never leave home for the doctor. You connect with Dr. Sharma online, and approved medication is sent to your Plainfield address in cold-pack packaging that shields it from heat during shipping.

What is the pricing for Plainfield residents?

You will pay $119 for the physician visit. Semaglutide starts at $166 a month or $499 for the 90-day option, and tirzepatide at $233 a month. The medication carries a separate charge. HSA, FSA, Klarna, and Affirm are all accepted, and there is no distance surcharge for Plainfield.

What areas of Plainfield do you serve?

We serve patients from across Plainfield by telehealth, including downtown Plainfield and the greater Union County area.

How soon can a Plainfield patient start treatment?

Most Plainfield patients complete the online intake in minutes and have Dr. Sharma's video review within about 48 hours. If you are a candidate and telehealth-eligible, medication ships shortly after, so many patients begin within roughly a week of starting.

Plainfield Residents, Get Started Today

Doctor review $119. Semaglutide from $166/mo. Tirzepatide from $233/mo. Medication separate.

Start My Journey →

New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Plainfield, New Jersey by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.

Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.